USPTO serial 97742599
MINDERA HEALTH
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- GANESH, HARINI
- Law office
- TMO LAW OFFICE 122
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MINDERA HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Johnny F. Manriquez
Johnny F. Manriquez AH GENERAL COUNSEL SERVICESPO BOX QDEL MAR, CA 92014United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Scientific and medical research, namely, analysis of cells, proteins and nucleic acids; Software as a service (SaaS) services and platform as a service (PaaS) featuring computer software platforms using machine-learning algorithms for collecting, storing, analyzing, sharing, reporting, and processing data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostic research, clinical research, drug development, drug development research, drug efficacy research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Hosting an online network service in the nature of an website that enables users to store, analyze and share data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Clinical diagnostic and consultation services for research purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of technical support services, namely, installation, administration, and troubleshooting of problems for computer software for storing, analyzing and sharing information in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Providing an online network service in the nature of an website that enables users to store, access, manage, analyze and share data for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Database design and development; RNA analysis services for scientific research purposes involving the identification and treatment of disease; Medical research services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 31, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 31, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 21, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 21, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 21, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 31, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 29, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 2, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 2, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 2, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 15, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 15, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 15, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 16, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Jan 16, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Oct 17, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 31, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 29, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 9, 2023 | NWAP | NEW APPLICATION ENTERED | — |